Elevance Health's stock price surged 6.22% in the pre-market trading session on Thursday. The healthcare insurer's shares rose following the company's better-than-expected quarterly earnings report.
Elevance Health reported a fourth-quarter adjusted profit of $3.84 per share, exceeding Wall Street analysts' estimates of $3.80 per share. The company's earnings beat was driven by lower-than-anticipated medical costs for its members during the quarter.
Furthermore, Elevance Health's total revenue for the quarter reached $45.44 billion, surpassing analysts' expectations of $44.92 billion. The company's strong revenue growth was supported by increased demand for its healthcare services.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。